Quantcast
Home / DC News / Watchdog cites conflicts in calling for new Yaz panel

Watchdog cites conflicts in calling for new Yaz panel

An independent watchdog group has asked the Food and Drug Administration to disregard a safety panel’s recommendation to keep the popular birth control drugs Yaz and Yasmin on the market, citing evidence that several panel members operated under conflicts of interest.